Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 13 | Busque PhilippeSVP, GLOBAL SALES AND SERVICES | Option exercise | M | — 4,833 sh | Mar 12, 2026 |
| 13 | Alvarado LuaniChief People Officer | Option exercise | M | — 697 sh | Mar 12, 2026 traded Mar 10, 2026 |
| 12 | Reilly TerenceEVP, Chief Brand Officer | Tax withholding | F | $136K 1,691 sh | Mar 12, 2026 traded Mar 11, 2026 |
| 12 | Gallman CariEVP, General Counsel | Other acquisition or disposition | J | — 94 sh | Mar 12, 2026 traded Mar 10, 2026 |
| 12 | Short Bartie WendyEVP, Corporate Affairs | Other acquisition or disposition | J | — 81 sh | Mar 12, 2026 traded Mar 10, 2026 |
| 12 | Campbell Rupert GeorgeEVP, President of HEYDUDE | Tax withholding | F | $82K 987 sh | Mar 12, 2026 traded Mar 10, 2026 |
| 12 | Sanderson Katherine ElizabethSee Remarks | Tax withholding | F | $77K 645 sh | Mar 12, 2026 traded Mar 12, 2026 |
| 12 | Morris Philip CDirector | Other acquisition or disposition | J | $1,069 31 sh | Mar 12, 2026 traded Mar 11, 2026 |
| 12 | Gallman CariEVP, General Counsel | Other acquisition or disposition | J | — 102 sh | Mar 12, 2026 traded Mar 10, 2026 |
| 12 | Hoch LynellePresident, Cell Therapy Org. | Other acquisition or disposition | J | — 113 sh | Mar 12, 2026 traded Mar 10, 2026 |
| 12 | Lenkowsky AdamEVP, Chief Commercial Officer | Other acquisition or disposition | J | — 216 sh | Mar 12, 2026 traded Mar 10, 2026 |
| 12 | Holzer Phil MSVP and Controller | Other acquisition or disposition | J | — 83 sh | Mar 12, 2026 traded Mar 10, 2026 |
| 12 | Holzer Phil MSVP and Controller | Other acquisition or disposition | J | — 91 sh | Mar 12, 2026 traded Mar 10, 2026 |
| 12 | Maersk-Moller KimberlyChief Commercial Officer | Option exercise | M | $193K 42.8K sh | Mar 12, 2026 traded Mar 10, 2026 |
| 12 | Lenkowsky AdamEVP, Chief Commercial Officer | Other acquisition or disposition | J | — 205 sh | Mar 12, 2026 traded Mar 10, 2026 |
| 12 | Hoch LynellePresident, Cell Therapy Org. | Other acquisition or disposition | J | — 94 sh | Mar 12, 2026 traded Mar 10, 2026 |
| 12 | Maersk-Moller KimberlyChief Commercial Officer | Tax withholding | F | $96K 21.3K sh | Mar 12, 2026 traded Mar 10, 2026 |
| 12 | Shea Thomas AnthonyDirector, CEO, 10% Owner | Tax withholding | F | $219K 9,258 sh | Mar 12, 2026 traded Mar 10, 2026 |
| 12 | Short Bartie WendyEVP, Corporate Affairs | Other acquisition or disposition | J | — 72 sh | Mar 12, 2026 traded Mar 10, 2026 |
| 12 | Mulally Ryan KEVP, Gen'l Counsel, Secretary | Tax withholding | F | $88K 219 sh | Mar 12, 2026 traded Mar 10, 2026 |
| 12 | Dewan SameerSenior Vice President | Tax withholding | F | $138K 3,542 sh | Mar 12, 2026 traded Mar 10, 2026 |
| 12 | Poole Ahn AmandaEVP, Chief People Officer | Other acquisition or disposition | J | — 91 sh | Mar 12, 2026 traded Mar 10, 2026 |
| 12 | Poole Ahn AmandaEVP, Chief People Officer | Other acquisition or disposition | J | — 87 sh | Mar 12, 2026 traded Mar 10, 2026 |
| 11 | McIntyre PamelaChief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $48K 2,015 sh | Mar 12, 2026 traded Mar 11, 2026 |
| 11 | Lin MarkEVP and CFO | Open-market sale · 10b5-1 plan | SELL | $341K 3,908 sh | Mar 12, 2026 traded Mar 11, 2026 |
| 10 | Bernstein HaroldPresident, R&D & CMO | Open-market sale · 10b5-1 plan | SELL | $18K 348 sh | Mar 12, 2026 traded Mar 10, 2026 |
| 10 | Raghavan VaidyanathanChief Technology Officer | Grant or award | A | — 16.1K sh | Mar 12, 2026 traded Mar 10, 2026 |
| 10 | Dutt SubirChief Sales Officer | Grant or award | A | — 21.8K sh | Mar 12, 2026 traded Mar 10, 2026 |
| 10 | Sahni Sanjeev SinghPresident | Grant or award | A | — 31.5K sh | Mar 12, 2026 traded Mar 10, 2026 |
| 9 | Busque PhilippeSVP, GLOBAL SALES AND SERVICES | Tax withholding | F | $3,858 912 sh | Mar 12, 2026 traded Mar 10, 2026 |
| 9 | Shibutani Hiroshi ChrisEVP, Chief Strategy Officer | Grant or award | A | — 11.8K sh | Mar 12, 2026 traded Mar 10, 2026 |
| 9 | Raths BarbaraEVP | Tax withholding | F | $1,375 30 sh | Mar 12, 2026 traded Mar 10, 2026 |
| 9 | Mulally Ryan KEVP, Gen'l Counsel, Secretary | Tax withholding | F | $12K 31 sh | Mar 12, 2026 traded Mar 10, 2026 |
| 9 | Mawson SimonSVP, Elec & Spec Materials | Grant or award | A | — 6 sh | Mar 12, 2026 traded Mar 10, 2026 |
| 9 | Ng Wei KingEVP, International | Grant or award | A | — 2,128 sh | Mar 12, 2026 traded Mar 10, 2026 |
| 9 | Dormo Jeffrey HarrisonSVP, Ref. and App. Solutions | Grant or award | A | — 7 sh | Mar 12, 2026 traded Mar 10, 2026 |
| 9 | Mawson SimonSVP, Elec & Spec Materials | Grant or award | A | — 20 sh | Mar 12, 2026 traded Mar 10, 2026 |
| 9 | Hoch LynellePresident, Cell Therapy Org. | Option exercise | M | — 6,304 sh | Mar 12, 2026 traded Mar 10, 2026 |
| 9 | Stevens MeredithChief Operations Officer | Option exercise | M | — 4,329 sh | Mar 12, 2026 traded Mar 10, 2026 |
| 9 | Dworkin TedChief Product Officer | Disposition to issuer | D | — 606.7K sh | Mar 12, 2026 traded Mar 10, 2026 |